Avalon GloboCare director receives 100,000 stock options

Avalon GloboCare Corp. director Felix Lourdes reported a compensation-related equity award.

Accepted by SEC EDGAR 07/13/2026 - 04:30 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Avalon GloboCare Corp. director Felix Lourdes reported a compensation-related equity award. He received options to purchase 100,000 shares of common stock on June 29, 2026, at an exercise price of $0.2820 per share. All option shares vested in full on the grant date. Following this grant, Lourdes holds 101,586 derivative option shares directly, which are scheduled to expire on June 29, 2029.

Insider Trade Summary

Grant/Award: 100,000 shares

Grant/Award 1 txn

Insider Felix Lourdes

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Options (right to buy) F1	100,000	$0.00	$0.00

Holdings After Transaction: Options (right to buy) — 101,586 contracts (Direct)

Footnotes (1)

1. F1. One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date.

Key Figures

Options Granted: 100,000 shares Exercise Price: $0.2820 per share Underlying Shares: 100,000 shares +3 more

6 metrics

Options Granted 100,000 shares Options (right to buy) granted on June 29, 2026

Exercise Price $0.2820 per share Conversion or exercise price of options granted June 29, 2026

Underlying Shares 100,000 shares Common Stock underlying the options granted

Post-Grant Option Holdings 101,586 shares Total derivative option shares held directly after the transaction

Expiration Date June 29, 2029 Scheduled expiration of the granted options

Vesting 100% on grant date All shares subject to the option vested in full on June 29, 2026

Key Terms

Grant, award, or other acquisition, exercise price, expiration date, vest in full, +1 more

5 terms

Grant, award, or other acquisition financial

"Transaction code description is "Grant, award, or other acquisition""

exercise price financial

"conversion or exercise price of $0.2820 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"options have an expiration date of June 29, 2029"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vest in full financial

"shares subject to the Option shall vest in full on the grant date"

Options (right to buy) financial

"security title is listed as Options (right to buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Avalon GloboCare (ALBT) director Felix Lourdes report in this Form 4?

Felix Lourdes reported a grant of options to buy 100,000 shares of Avalon GloboCare common stock. The options were awarded on June 29, 2026, as a compensation-related acquisition under code “A”.

What is the exercise price of the options granted to Felix Lourdes at ALBT?

The options granted to Felix Lourdes have an exercise price of $0.2820 per share. This is the price at which he can purchase Avalon GloboCare common shares before the options’ expiration on June 29, 2029.

How many Avalon GloboCare (ALBT) option shares does Felix Lourdes hold after this grant?

After the grant, Felix Lourdes holds 101,586 option shares relating to Avalon GloboCare common stock. This figure represents his total derivative position in options following the June 29, 2026 award.

When do the options granted to Felix Lourdes at Avalon GloboCare expire?

The options awarded to Felix Lourdes on June 29, 2026 expire on June 29, 2029. He may exercise the options at $0.2820 per share any time before that expiration date, subject to plan terms.

How do the options granted to Felix Lourdes at ALBT vest?

The options granted to Felix Lourdes vest 100% on the grant date. According to the disclosure, all 100,000 option shares became fully exercisable immediately on June 29, 2026, rather than vesting over time.

Is the Form 4 for Felix Lourdes a market purchase or sale of ALBT shares?

The Form 4 reflects a grant/award acquisition of options, coded “A,” not an open-market trade. It documents compensation in the form of stock options, with no reported market buying or selling of common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Felix Lourdes

(Last) (First) (Middle)

C/O AVALON GLOBOCARE CORP.

4400 ROUTE 9, SUITE 3100

(Street)

FREEHOLD NEW JERSEY 07728

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Avalon GloboCare Corp. [ ALBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (right to buy)	$0.282	06/29/2026		A		100,000		06/29/2026(1)	06/29/2029	Common Stock	100,000	$0	101,586	D

Explanation of Responses:

1. One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date.

	/s/ Lourdes Felix	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)